Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators Grant US-11484530-B2 United States of America 01 Nov 2022
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof Grant US-RE49251-E1 United States of America 18 Oct 2022
Methods for suppressing or alleviating primary or secondary progressive multiple… Grant US-11167003-B2 United States of America 09 Nov 2021
Pharmaceutical compositions comprising glitazones and NRF2 activators Grant US-10426763-B2 United States of America 01 Oct 2019
Process for manufacturing glatiramer acetate product Grant US-9763993-B2 United States of America 19 Sep 2017
Pharmaceutical compositions comprising glitazones and Nrf2 activators Grant US-9504679-B2 United States of America 29 Nov 2016